CA Lawmakers Target Insurance Delays for Rare Disease Care California lawmakers introduce bipartisan AB 1887 to eliminate prior authorization and step therapy requirements for FDA-approved rare disease treatments

TY #SantaMonicaDailyPress for covering my bill #AB1887, to prohibit insurance companies from requiring prior authorization or "step therapy" for FDA-approved rare disease treatments prescribed by specialists.

LINK: www.smdp.com/california-l...

Today is #RareDiseaseDay, a day that’s deeply personal for me.
 
My sister Jackie fought ALS until her passing in 2020. This past week, I joined patients, families & advocates to share details on #AB1887, to end “fail-first” requirements for FDA-approved treatments.
 
We must do better.

Patients with rare diseases shouldn’t face insurance barriers.
I’ve introduced #AB1887 to remove prior authorization & step therapy for FDA-approved rare disease treatments—so doctors, not insurers, make medical decisions.

TY to sponsor #CAChronicCareCoalition!